China NMPA Drug Inspection - Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. - Salt-based Psoralea corylifolia

The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on April 2, 2018, detailing the results of drug quality supervision and sampling inspections in Tianjin, China. The inspections aimed to strengthen drug oversight and ensure public safety. Three batches of traditional Chinese medicine decoction pieces were found to be substandard, failing to meet the quality specifications of the Chinese Pharmacopoeia (2010 and 2015 Editions).

Key violations included Anguo Changda Traditional Chinese Medicine Decoction Pieces Co., Ltd.'s Amomum villosum, which failed content determination for Borneol Acetate. Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. (Sichuan) had substandard Salt-processed Psoralea corylifolia due to content issues. Dalian Quanjian Traditional Chinese Medicine Pieces Co., Ltd.'s Alum was found to contain unqualified levels of Ammonium Salts, indicating purity concerns.

Under the Tianjin Municipal Drug Quality Announcement regulatory framework, local market supervision and law enforcement departments were mandated to promptly investigate and address these substandard drugs. The required actions emphasize ensuring drug quality and safety for the public, with a commitment to continued rigorous supervision and risk prevention for traditional Chinese medicine decoction pieces.